Maraviroc: Selective CCR5 Antagonist for HIV and Neuroinf...
2026-01-19
Maraviroc (UK-427857, Selzentry) stands out as a selective CCR5 antagonist with proven efficacy in HIV-1 entry inhibition and neuroinflammation modulation. This guide demystifies experimental workflows, troubleshooting strategies, and advanced applications, empowering researchers to drive impactful discoveries in HIV tropism and ischemic stroke models.